News: NOX Noxopharm Announces Results From Novel Dual-Cell Therapy Pancreatic Cancer Study

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Sept 14 (Reuters) - Noxopharm Ltd (NOX) :

    • ANNOUNCES RESULTS FROM NOVEL 'DUAL-CELL' THERAPY PANCREATIC CANCER STUDY
    • MAJOR FINDINGS WERE THAT CRO-67 KILLED TUMOUR CELLS AS WELL AS BARRIER CELLS IN SAMPLES TAKEN FROM SIX PATIENTS
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
9.9¢
Change
0.005(5.32%)
Mkt cap ! $27.47M
Open High Low Value Volume
9.3¢ 10.0¢ 9.3¢ $27.24K 282.8K

Buyers (Bids)

No. Vol. Price($)
1 22914 9.9¢
 

Sellers (Offers)

Price($) Vol. No.
10.0¢ 36540 1
View Market Depth
Last trade - 11.16am 10/09/2025 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.